Chenthamarakshan Vasu to Immune Tolerance
This is a "connection" page, showing publications Chenthamarakshan Vasu has written about Immune Tolerance.
Connection Strength
1.354
-
Engineered Dendritic Cell-Directed Concurrent Activation of Multiple T cell Inhibitory Pathways Induces Robust Immune Tolerance. Sci Rep. 2019 08 19; 9(1):12065.
Score: 0.646
-
Targeted CTLA-4 engagement induces CD4+CD25+CTLA-4high T regulatory cells with target (allo)antigen specificity. J Immunol. 2004 Aug 15; 173(4):2866-76.
Score: 0.228
-
Activation of T cell checkpoint pathways during ?-cell antigen presentation by engineered dendritic cells promotes protection from type 1 diabetes. Immunology. 2022 07; 166(3):341-356.
Score: 0.194
-
Complex dietary polysaccharide modulates gut immune function and microbiota, and promotes protection from autoimmune diabetes. Immunology. 2019 05; 157(1):70-85.
Score: 0.156
-
Enhanced engagement of CTLA-4 induces antigen-specific CD4+CD25+Foxp3+ and CD4+CD25- TGF-beta 1+ adaptive regulatory T cells. J Immunol. 2007 Oct 15; 179(8):5191-203.
Score: 0.071
-
GP96 is a GARP chaperone and controls regulatory T cell functions. J Clin Invest. 2015 Feb; 125(2):859-69.
Score: 0.029
-
Reducing CD73 expression by IL1?-Programmed Th17 cells improves immunotherapeutic control of tumors. Cancer Res. 2014 Nov 01; 74(21):6048-59.
Score: 0.029